HSCS
HSCS
NASDAQ · Health Care

Heartsciences Inc

$2.06
+0.00 (+0.00%)
As of Aug 15, 2:35 AM ET ·
Financial Highlights (FY 2026)
Revenue
6.2K
Net Income
-13,578,416
Gross Margin
59.0%
Profit Margin
-211,617.6%
Rev Growth
-6.0%
D/E Ratio
16.02
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 59.0% 59.0% 46.4% 46.4%
Operating Margin -194,742.3% -175,282.1% 16.1% 16.8%
Profit Margin -211,617.6% -201,036.7% 17.0% 13.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 6.2K 6.6K 3.30M 3.40M
Gross Profit 3.7K 3.9K 1.53M 1.58M
Operating Income -12,149,975 -11,631,717 530.1K 570.8K
Net Income -13,578,416 -12,999,228 560.2K 453.4K
Gross Margin 59.0% 59.0% 46.4% 46.4%
Operating Margin -194,742.3% -175,282.1% 16.1% 16.8%
Profit Margin -211,617.6% -201,036.7% 17.0% 13.3%
Rev Growth -6.0% -6.0% +13.2% +5.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 3.78M 3.78M 3.60M 4.54M
Total Equity 235.9K 235.9K 4.32M 3.69M
D/E Ratio 16.02 16.02 0.83 1.23
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -12,454,193 -12,585,345 944.9K 908.1K
Free Cash Flow 381.1K 454.7K